Cargando…
Improvement in subclinical cognitive dysfunction with thyroxine therapy in hypothyroidism: A study from tertiary care center
AIM: To evaluate the effect of hypothyroidism (both overt and subclinical) on cognitive function using latencies of P300 auditory evoked potentials (AEPs). P300 latency suggests that shorter latency times are related to better cognitive performance. P300 latencies were also done after thyroxine repl...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673814/ https://www.ncbi.nlm.nih.gov/pubmed/26693436 http://dx.doi.org/10.4103/2230-8210.167547 |
_version_ | 1782404814576025600 |
---|---|
author | Paladugu, Sridevi Hanmayyagari, Babul Reddy Kudugunti, Neelaveni Reddy, Ram Sahay, Rakesh Ramesh, Jayanthy |
author_facet | Paladugu, Sridevi Hanmayyagari, Babul Reddy Kudugunti, Neelaveni Reddy, Ram Sahay, Rakesh Ramesh, Jayanthy |
author_sort | Paladugu, Sridevi |
collection | PubMed |
description | AIM: To evaluate the effect of hypothyroidism (both overt and subclinical) on cognitive function using latencies of P300 auditory evoked potentials (AEPs). P300 latency suggests that shorter latency times are related to better cognitive performance. P300 latencies were also done after thyroxine replacement to see the effect of treatment on cognitive function. MATERIALS AND METHODS: Biochemically proven new onset cases with hypothyroidism (overt and subclinical) were enrolled into the study, AEPs of these two groups when compared with matched controls. After detailed history and physical examination, P300 potentials were recorded at two points Cz and Pz (Cz: On the midline of the head at the vertex, Pz: On the midline of the head between the vertex and occipital protuberance) using a Nicolet Viking Select neuro diagnostic system version 10.0. The study was done in electrophysiology lab in Osmania Medical College. RESULTS: A patient characteristics of both cases and controls were comparable. The cases consisted of two groups, overt hypothyroid cases 24, mean thyroid stimulating hormone (TSH) values in them was 94, subclinical cases 21 in whom mean TSH value was 12.3. Mean P300 latencies of all cases at Cz was 342.42 ± 29.5 ms, and at Pz was 345.4 ± 30 ms. Mean P300 latencies of controls at Cz was 296.4 ± 34 ms and at Pz was 297.9 ± 33 ms (difference in P < 0.001). Mean P300 values in overt cases were 362.6 ± 32.9 ms at Cz, and at Pz it was 362.5 ± 33.9 ms. Mean P300 values in subclinical cases were 319.3 ± 30.9 ms at Cz, and at Pz it was 316.4 ± 27.9 ms. P300 values in overt cases were highly significant as compared to controls, and P300 values in the subclinical cases versus controls were also significant (P < 0.001). CONCLUSION: P300 latency prolongation in both clinical and subclinical hypothyroid cases shows that cognitive function is affected adversely in hypothyroidism including the subclinical hypothyroid cases. Larger studies evaluating the effect of subclinical hypothyroidism on cognitive function are needed with objective means such as the AEPs P300. |
format | Online Article Text |
id | pubmed-4673814 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-46738142015-12-21 Improvement in subclinical cognitive dysfunction with thyroxine therapy in hypothyroidism: A study from tertiary care center Paladugu, Sridevi Hanmayyagari, Babul Reddy Kudugunti, Neelaveni Reddy, Ram Sahay, Rakesh Ramesh, Jayanthy Indian J Endocrinol Metab Original Article AIM: To evaluate the effect of hypothyroidism (both overt and subclinical) on cognitive function using latencies of P300 auditory evoked potentials (AEPs). P300 latency suggests that shorter latency times are related to better cognitive performance. P300 latencies were also done after thyroxine replacement to see the effect of treatment on cognitive function. MATERIALS AND METHODS: Biochemically proven new onset cases with hypothyroidism (overt and subclinical) were enrolled into the study, AEPs of these two groups when compared with matched controls. After detailed history and physical examination, P300 potentials were recorded at two points Cz and Pz (Cz: On the midline of the head at the vertex, Pz: On the midline of the head between the vertex and occipital protuberance) using a Nicolet Viking Select neuro diagnostic system version 10.0. The study was done in electrophysiology lab in Osmania Medical College. RESULTS: A patient characteristics of both cases and controls were comparable. The cases consisted of two groups, overt hypothyroid cases 24, mean thyroid stimulating hormone (TSH) values in them was 94, subclinical cases 21 in whom mean TSH value was 12.3. Mean P300 latencies of all cases at Cz was 342.42 ± 29.5 ms, and at Pz was 345.4 ± 30 ms. Mean P300 latencies of controls at Cz was 296.4 ± 34 ms and at Pz was 297.9 ± 33 ms (difference in P < 0.001). Mean P300 values in overt cases were 362.6 ± 32.9 ms at Cz, and at Pz it was 362.5 ± 33.9 ms. Mean P300 values in subclinical cases were 319.3 ± 30.9 ms at Cz, and at Pz it was 316.4 ± 27.9 ms. P300 values in overt cases were highly significant as compared to controls, and P300 values in the subclinical cases versus controls were also significant (P < 0.001). CONCLUSION: P300 latency prolongation in both clinical and subclinical hypothyroid cases shows that cognitive function is affected adversely in hypothyroidism including the subclinical hypothyroid cases. Larger studies evaluating the effect of subclinical hypothyroidism on cognitive function are needed with objective means such as the AEPs P300. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4673814/ /pubmed/26693436 http://dx.doi.org/10.4103/2230-8210.167547 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution NonCommercial ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Paladugu, Sridevi Hanmayyagari, Babul Reddy Kudugunti, Neelaveni Reddy, Ram Sahay, Rakesh Ramesh, Jayanthy Improvement in subclinical cognitive dysfunction with thyroxine therapy in hypothyroidism: A study from tertiary care center |
title | Improvement in subclinical cognitive dysfunction with thyroxine therapy in hypothyroidism: A study from tertiary care center |
title_full | Improvement in subclinical cognitive dysfunction with thyroxine therapy in hypothyroidism: A study from tertiary care center |
title_fullStr | Improvement in subclinical cognitive dysfunction with thyroxine therapy in hypothyroidism: A study from tertiary care center |
title_full_unstemmed | Improvement in subclinical cognitive dysfunction with thyroxine therapy in hypothyroidism: A study from tertiary care center |
title_short | Improvement in subclinical cognitive dysfunction with thyroxine therapy in hypothyroidism: A study from tertiary care center |
title_sort | improvement in subclinical cognitive dysfunction with thyroxine therapy in hypothyroidism: a study from tertiary care center |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673814/ https://www.ncbi.nlm.nih.gov/pubmed/26693436 http://dx.doi.org/10.4103/2230-8210.167547 |
work_keys_str_mv | AT paladugusridevi improvementinsubclinicalcognitivedysfunctionwiththyroxinetherapyinhypothyroidismastudyfromtertiarycarecenter AT hanmayyagaribabulreddy improvementinsubclinicalcognitivedysfunctionwiththyroxinetherapyinhypothyroidismastudyfromtertiarycarecenter AT kuduguntineelaveni improvementinsubclinicalcognitivedysfunctionwiththyroxinetherapyinhypothyroidismastudyfromtertiarycarecenter AT reddyram improvementinsubclinicalcognitivedysfunctionwiththyroxinetherapyinhypothyroidismastudyfromtertiarycarecenter AT sahayrakesh improvementinsubclinicalcognitivedysfunctionwiththyroxinetherapyinhypothyroidismastudyfromtertiarycarecenter AT rameshjayanthy improvementinsubclinicalcognitivedysfunctionwiththyroxinetherapyinhypothyroidismastudyfromtertiarycarecenter |